Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-21-3p


Loading... Please wait, this might take a few seconds...



Filters
Interactions: 1955, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
HNF4A hsa-miR-21-3p low: 2 high: 0 1 2 1 -
Low-throughput experiments (0 positive, 2 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Maria Hatziapostolou et al. 2011 RP Liver HEP3B HEP3B N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Luciferase Reporter Assay NEGATIVE DIRECT TarBase 8.0
Maria Hatziapostolou et al. 2011 RP Liver HEPG2 HEPG2 N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Luciferase Reporter Assay NEGATIVE DIRECT TarBase 8.0
TXNRD1 hsa-miR-21-3p low: 0 high: 9 5 9 5 -
High-throughput experiments (9 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr12:104348796-104348812 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr12:104348796-104348812 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:104348796-104348812 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD1 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:104348796-104348812 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:104348796-104348812 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr12:104348796-104348812 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:104348796-104348812 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:104348796-104348812 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr12:104321161-104321188 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MAP1B hsa-miR-21-3p low: 0 high: 9 3 6 4 0.756
High-throughput experiments (9 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland MDAMB231 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:72209330-72209348 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:72209330-72209348 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr5:72209330-72209348 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr5:72209330-72209348 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr5:72209330-72209348 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr5:72209330-72209348 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr5:72209330-72209348 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:72209330-72209348 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HMSC N/A N/A
Location Method Result Regulation Validation Type Source
chr5:72209330-72209348 HITS-CLIP POSITIVE DIRECT TarBase 7.0
AHNAK hsa-miR-21-3p low: 0 high: 8 2 2 2 0.452
High-throughput experiments (8 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr11:62519854-62519871 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr11:62531860-62531879 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:62531671-62531693 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:62529664-62529681 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:62528527-62528555 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:62527942-62527954 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:62519854-62519871 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:62519374-62519400 HITS-CLIP POSITIVE DIRECT TarBase 7.0
WDR74 hsa-miR-21-3p low: 0 high: 7 2 2 2 -
High-throughput experiments (7 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr11:62841647-62841665 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr11:62841647-62841665 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:62841647-62841665 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr11:62841647-62841665 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr11:62841647-62841665 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:62841647-62841665 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:62841647-62841665 HITS-CLIP POSITIVE DIRECT TarBase 7.0
GTF2A1 hsa-miR-21-3p low: 0 high: 6 5 6 5 0.462
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr14:81178534-81178558 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr14:81178534-81178558 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr14:81176357-81176381 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr14:81178534-81178558 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr14:81176357-81176381 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr14:81176357-81176381 HITS-CLIP POSITIVE DIRECT TarBase 7.0
HIST1H4E hsa-miR-21-3p low: 0 high: 6 3 5 4 -
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr6:26204802-26204829 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr6:26204802-26204829 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr6:26204802-26204829 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr6:26204802-26204829 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:26204802-26204829 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HMSC N/A N/A
Location Method Result Regulation Validation Type Source
chr6:26204802-26204829 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NUPL1 hsa-miR-21-3p low: 0 high: 6 1 1 1 -
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr13:25341945-25341969 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr13:25341945-25341969 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr13:25341945-25341969 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr13:25341945-25341969 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr13:25341945-25341969 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr13:25341945-25341969 HITS-CLIP POSITIVE DIRECT TarBase 7.0
INO80D hsa-miR-21-3p low: 0 high: 5 2 5 2 0.494
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr2:206000799-206000815 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD1 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:206000799-206000815 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:206000799-206000815 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:206000799-206000815 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:206000799-206000815 PAR-CLIP POSITIVE DIRECT TarBase 7.0
WNK1 hsa-miR-21-3p low: 0 high: 5 2 2 2 -
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:911330-911357 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr12:911330-911357 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr12:911330-911357 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr12:911330-911357 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr12:911330-911357 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SRSF1 hsa-miR-21-3p low: 0 high: 4 2 2 2 0.657
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr17:58005877-58005895 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr17:58005877-58005895 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:58005292-58005314 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr17:58004616-58004641 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SON hsa-miR-21-3p low: 0 high: 4 2 4 3 -
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr21:33550955-33550983 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr21:33553956-33553983 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS27A N/A N/A
Location Method Result Regulation Validation Type Source
chr21:33553956-33553983 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HMSC N/A N/A
Location Method Result Regulation Validation Type Source
chr21:33553956-33553983 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SRSF2 hsa-miR-21-3p low: 0 high: 4 2 3 2 0.852
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr17:76734129-76734144 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:76734129-76734144 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr17:76734509-76734533 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:76734509-76734533 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ARL6IP1 hsa-miR-21-3p low: 0 high: 4 2 2 2 0.475
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr16:18791958-18791976 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr16:18791958-18791976 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr16:18791958-18791976 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:18791958-18791976 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PRPF8 hsa-miR-21-3p low: 0 high: 4 2 3 3 -
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:1650691-1650713 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr17:1674600-1674619 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:1650691-1650713 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HMSC N/A N/A
Location Method Result Regulation Validation Type Source
chr17:1650691-1650713 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MAT2A hsa-miR-21-3p low: 0 high: 4 2 2 2 0.893
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr2:85545038-85545059 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr2:85545101-85545119 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr2:85541676-85541703 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr2:85541296-85541317 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CCND1 hsa-miR-21-3p low: 0 high: 4 5 5 5 0.463
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Romay MC et al. 2015 MA Aortic Endothelium HAEC N/A 24hrs post-transfection, Overexpression
Location Method Result Regulation Validation Type Source
UNKNOWN Microarrays POSITIVE INDIRECT TarBase 8.0
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr11:69652561-69652580 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr11:69652561-69652580 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr11:69652561-69652580 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Other Databases
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 O N/A N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Other UNKNOWN UNKNOWN miRTarBase
SDC4 hsa-miR-21-3p low: 0 high: 4 4 4 4 0.645
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Romay MC et al. 2015 MA Aortic Endothelium HAEC N/A 24hrs post-transfection, Overexpression
Location Method Result Regulation Validation Type Source
UNKNOWN Microarrays POSITIVE INDIRECT TarBase 8.0
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:45325915-45325931 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr20:45325915-45325931 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:45325915-45325931 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CDK6 hsa-miR-21-3p low: 0 high: 4 3 3 2 0.982
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Romay MC et al. 2015 MA Aortic Endothelium HAEC N/A 24hrs post-transfection, Overexpression
Location Method Result Regulation Validation Type Source
UNKNOWN Microarrays POSITIVE INDIRECT TarBase 8.0
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr7:92613818-92613839 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr7:92607465-92607489 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr7:92613818-92613839 PAR-CLIP POSITIVE DIRECT TarBase 7.0
FAM13B hsa-miR-21-3p low: 0 high: 3 2 3 2 0.508
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland MDAMB231 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:137959694-137959721 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:137959694-137959721 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Umbilical Vein HUVEC N/A N/A
Location Method Result Regulation Validation Type Source
chr5:137959694-137959721 HITS-CLIP POSITIVE DIRECT TarBase 7.0